Special Opportunities Fund Inc
Organization details
- Legal name
- Special Opportunities Fund Inc
- Former names
- Insured Municipal Income Fund Inc Painewebber Premier Insured Municipal Income Fund Inc
- Ownership
- Public
- Status
- Active
- Jurisdiction of incorporation
- Maryland
- Headquarters city
- Cincinnati
- Headquarters state / province
- Ohio
- Headquarters country
- United States
- Fiscal year end
- March
- Ticker symbol
- SPE
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000897802
- EIN
- 13-3702911
Board of directors
-
Andrew Dakos · Director · President and CEOSince 2024
-
Charles C. Walden · DirectorSince 2024
-
Jaclyn L. Rothchild · DirectorSince 2025
-
Moritz A. Sell · DirectorSince 2026
-
Phillip Goldstein · Director · Chairman and SecretarySince 2023
Chief executives
Board connections
4 of this board's directors also sit on 6 other boards.
- via Andrew Dakos, Moritz A. Sell and Phillip Goldstein
- via Andrew Dakos, Moritz A. Sell and Phillip Goldstein
- via Andrew Dakos
- via Jaclyn L. Rothchild
- via Moritz A. Sell
- via Moritz A. Sell
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $150,194
- 4 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | Andrew Dakos Director, Officer (President and CEO), Affiliate of Adviser | Open-market sale | −5,184 | $14.11 | $73,146 |
| Jun 3, 2026 | Andrew Dakos Director, Officer (President and CEO), Affiliate of Adviser | Open-market sale | −133 | $14.07 | $1,871 |
| Jun 2, 2026 | Andrew Dakos Director, Officer (President and CEO), Affiliate of Adviser | Open-market sale | −1,077 | $14.02 | $15,100 |
| Dec 30, 2025 | Andrew Dakos Director, Officer (President) | Open-market sale | −4,098 | $14.66 | $60,077 |
| Apr 4, 2025 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +3,000 | $13.80 | $41,400 |
| Sep 20, 2024 | Andrew Dakos Director, Officer (President) | Open-market sale | −377 | $13.74 | $5,180 |
| Dec 28, 2023 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +44 | $11.75 | $517 |
| Dec 28, 2023 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +1,319 | $11.78 | $15,538 |
| Apr 6, 2023 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +5,000 | $10.85 | $54,250 |
| Apr 5, 2023 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +2,400 | $10.85 | $26,040 |
| Mar 30, 2023 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +1,568 | $10.85 | $17,013 |
| Mar 29, 2023 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +675 | $10.74 | $7,250 |
| Feb 3, 2023 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +2,000 | $11.85 | $23,700 |
| Jan 30, 2023 | Phillip Goldstein Director, Officer (Chairman and Secretary) | Open-market purchase | +2,000 | $11.63 | $23,260 |
Questions about Special Opportunities Fund Inc
Who is the CEO of Special Opportunities Fund Inc?
Andrew Dakos is Special Opportunities Fund Inc's President and CEO.
How many directors are on Special Opportunities Fund Inc's board?
Special Opportunities Fund Inc's board has 5 directors: Andrew Dakos, Charles C. Walden, Jaclyn L. Rothchild, Moritz A. Sell and Phillip Goldstein.
Are Special Opportunities Fund Inc insiders buying or selling shares?
Over the last 12 months, Special Opportunities Fund Inc insiders made no open-market purchases and sold $150,194 of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="special-opportunities-fund-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.